Biotechnology
Healthcare
Investing News
Life Style
Market News
Medical Use
Pharmaceutical
Products
The Market Buzz
Your Environment
Eli Lilly Seeks to Cut Insulin Costs as Walmart Debuts Lower-Price Rival
Walmart introduced a less expensive version of analog insulin and Eli Lilly (NYSE: LLY) CEO David Ricks revealed it is ready for the competition. Walmart announced Tuesday that it is...
